Page 146 - Read Online
P. 146

Dokko et al. Vessel Plus 2022;6:53                                         Vessel Plus
               DOI: 10.20517/2574-1209.2022.11



               Original Article                                                              Open Access



               Predictors and risk-adjusted outcomes of new-onset

               postoperative atrial fibrillation in repeat surgical and
               valve-in-valve transcatheter aortic valve replacement


                                           1
                                                                     2
                                                                                     2
                                                                                                    1
                         1
                                                        1
               Julia Dokko , Samantha Novotny , Natalie Kolba , Sohaib Agha , Ashutosh Yaligar , Vineet Tummala , Puja
                                                       2
                       3
                                      2
                                                                       2,#
               B. Parikh , Aurora D. Pryor , Henry J. Tannous , A. Laurie Shroyer , Thomas Bilfinger 2,#
               1
                Renaissance School of Medicine, Undergraduate Medical Education, Stony Brook University, Stony Brook, NY 11794-8343, USA.
               2
                Department of Surgery, Renaissance School of Medicine, Stony Brook, NY 11794-8191, USA.
               3
                Department of Medicine, Renaissance School of Medicine, Stony Brook, NY 11794-8167, USA.
               #
                A. Laurie Shroyer and Thomas Bilfinger are listed as co-senior authors.
               Correspondence to: Prof. A. Laurie Shroyer, Department of Surgery, Stony Brook Renaissance School of Medicine, MART level 8,
               room 08-014, 100 Nicolls Road, Stony Brook, NY 11794-8191, USA. E-mail: AnnieLaurie.Shroyer@stonybrookmedicine.edu
               How to cite this article: Dokko J, Novotny S, Kolba N, Agha S, Yaligar A, Tummala V, Parikh PB, Pryor AD, Tannous HJ, Shroyer
               AL, Bilfinger T. Predictors and risk-adjusted outcomes of new-onset postoperative atrial fibrillation in repeat surgical and valve-
               in-valve transcatheter aortic valve replacement. Vessel Plus 2022;6:53. https://dx.doi.org/10.20517/2574-1209.2022.11
               Received: 28 Feb 2022  First Decision: 6 May 2022  Revised: 4 Jun 2022  Accepted: 11 Jul 2022  Published: 10 Oct 2022
               Academic Editor: Frank W. Sellke   Copy Editor: Haixia Wang    Production Editor: Haixia Wang
               Abstract
               Aim: New-onset postoperative atrial fibrillation/flutter (POAF/AFL) complications have not been well studied for
               repeat aortic valve replacements (r-AVR); this study identified risk factors predisposing to POAF/AFL and
               POAF/AFL’s effect upon risk-adjusted outcomes.

               Methods: Using New York State’s Statewide Planning and Research Cooperative System records (2005-2018),
               multivariable forward selection models identified risks predictive of POAF/AFL. To identify POAF/AFL’s impact
               upon risk-adjusted mortality/morbidity (MM) and 30-day readmission (READMIT), forward selection logistic
               regression models applied Firth bias correction to address data sparsity.

               Results: Of the 242 r-AVR patients, 147 underwent repeat surgical aortic valve replacements (r-SAVR) and 95
               underwent valve-in-valve transcatheter aortic valve replacements (ViV-TAVR); 39.46% of r-SAVR and 43.16% of
               ViV-TAVR patients had POAF/AFL. R-SAVR patients with POAF/AFL were older (69.7 ± 11.1 vs. 56.7 ± 13.2 years,
               P < 0.01) compared to R-SAVR patients without POAF/AFL. Multivariable models identified an enhanced
               POAF/AFL risk for elderly (OR: 1.05, 95%CI: 1.03-1.07, P < 0.01) and cerebral vascular disease (OR: 2.18, 95%CI:
               1.05-4.55, P = 0.04) patients.





                           © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                             www.vpjournal.net
   141   142   143   144   145   146   147   148   149   150   151